Efficacy of Letrozole in Recurrent Ovarian Cancer

NCT04421547 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

86

Enrollment

OTHER

Sponsor class

Stopped Logistical problems impacting the speed of enrolment

Conditions

Epithelial Ovarian Cancer

Interventions

DRUG: Letrozole 2.5mg
DRUG: Standard single agent chemotherapy

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS